Here at GeneFirst, we pride ourselves on the innovative technologies that go into making our solutions.   

GeneFirst's MPA technology overcomes the limit on real-time PCR multiplexing and allows differentiation of up to six different targets per fluorescence channel.

GeneFirst’s proprietary MMD-PCR technology is real-time PCR-based and intended for detection of cancer-associated mutations in DNA.

ATOM-seq™ reduces error rates associated with sequencing, and is suitable for detecting rare mutations in blood-borne ctDNA.

With at least 10-fold increase in sensitivity than conventional PCR, PCDR produces twice as much material in each round of thermal cycling.  

+44 (0) 1865 407400

Culham Science Centre, Oxfordshire, UK.  OX14 3DB

© 2020 GeneFirst Ltd.  All rights reserved.  Privacy Policy |

COVID-19 Detection Kits (CE-IVD)
Now Available
Please click here for more information.